 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0070990	snRNP binding	1	3.749979e-6	1.382992e-2	1.382992e-2	2.666681e+5	3.749979e-6	1	3.749979e-6	1.000000e+0	1	5.542930e-5	2.044233e-1	2.044233e-1	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	PRPF31
GO Molecular Function	GO:0043021	ribonucleoprotein complex binding	2	3.134582e-3	1.000000e+0	1.000000e+0	3.190218e+2	3.134582e-3	1	3.134582e-3	1.000000e+0	2	3.381187e-3	1.000000e+0	1.000000e+0	2.957541e+2	3.381187e-3	1	61	1.000000e+0	1.639344e-2	unnamed	PRPF31
GO Molecular Function	GO:0003723	RNA binding	3	7.115189e-2	1.000000e+0	1.000000e+0	1.405444e+1	7.115189e-2	1	7.115189e-2	1.000000e+0	3	5.027438e-2	1.000000e+0	1.000000e+0	1.989085e+1	5.027438e-2	1	907	1.000000e+0	1.102536e-3	unnamed	PRPF31
GO Molecular Function	GO:0003676	nucleic acid binding	4	2.841930e-1	1.000000e+0	1.000000e+0	3.518736e+0	2.841930e-1	1	2.841930e-1	1.000000e+0	4	1.882933e-1	1.000000e+0	1.000000e+0	5.310863e+0	1.882933e-1	1	3397	1.000000e+0	2.943774e-4	unnamed	PRPF31
GO Molecular Function	GO:1901363	heterocyclic compound binding	5	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	5	2.937753e-1	1.000000e+0	1.000000e+0	3.403962e+0	2.937753e-1	1	5300	1.000000e+0	1.886792e-4	unnamed	PRPF31
GO Molecular Function	GO:0097159	organic cyclic compound binding	6	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	6	2.978216e-1	1.000000e+0	1.000000e+0	3.357714e+0	2.978216e-1	1	5373	1.000000e+0	1.861158e-4	unnamed	PRPF31
GO Molecular Function	GO:0005515	protein binding	7	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	7	4.432681e-1	1.000000e+0	1.000000e+0	2.255971e+0	4.432681e-1	1	7997	1.000000e+0	1.250469e-4	unnamed	PRPF31
GO Molecular Function	GO:0005488	binding	8	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	8	6.747963e-1	1.000000e+0	1.000000e+0	1.481929e+0	6.747963e-1	1	12174	1.000000e+0	8.214227e-5	unnamed	PRPF31
GO Biological Process	GO:0000244	spliceosomal tri-snRNP complex assembly	1	2.758485e-4	1.000000e+0	1.000000e+0	3.625178e+3	2.758485e-4	1	2.758485e-4	1.000000e+0	1	3.325758e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	6	1.000000e+0	1.666667e-1	unnamed	PRPF31
GO Biological Process	GO:0000387	spliceosomal snRNP assembly	2	1.840088e-3	1.000000e+0	1.000000e+0	5.434522e+2	1.840088e-3	1	1.840088e-3	1.000000e+0	2	1.773738e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	32	1.000000e+0	3.125000e-2	unnamed	PRPF31
GO Biological Process	GO:0022618	ribonucleoprotein complex assembly	3	1.086742e-2	1.000000e+0	1.000000e+0	9.201820e+1	1.086742e-2	1	1.086742e-2	1.000000e+0	3	6.984092e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	126	1.000000e+0	7.936508e-3	unnamed	PRPF31
GO Biological Process	GO:0071826	ribonucleoprotein complex subunit organization	4	1.122973e-2	1.000000e+0	1.000000e+0	8.904937e+1	1.122973e-2	1	1.122973e-2	1.000000e+0	4	7.316668e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	132	1.000000e+0	7.575758e-3	unnamed	PRPF31
GO Biological Process	GO:0000398	mRNA splicing, via spliceosome	5	1.456013e-2	1.000000e+0	1.000000e+0	6.868069e+1	1.456013e-2	1	1.456013e-2	1.000000e+0	5	1.125215e-2	1.000000e+0	1.000000e+0	8.887192e+1	1.125215e-2	1	203	1.000000e+0	4.926108e-3	unnamed	PRPF31
GO Biological Process	GO:0000375	RNA splicing, via transesterification reactions	6	1.476894e-2	1.000000e+0	1.000000e+0	6.770966e+1	1.476894e-2	1	1.476894e-2	1.000000e+0	6	1.152929e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	208	1.000000e+0	4.807692e-3	unnamed	PRPF31
GO Biological Process	GO:0022613	ribonucleoprotein complex biogenesis	7	1.886121e-2	1.000000e+0	1.000000e+0	5.301888e+1	1.886121e-2	1	1.886121e-2	1.000000e+0	7	1.446705e-2	1.000000e+0	1.000000e+0	6.912261e+1	1.446705e-2	1	261	1.000000e+0	3.831418e-3	unnamed	PRPF31
GO Biological Process	GO:0008380	RNA splicing	8	2.612073e-2	1.000000e+0	1.000000e+0	3.828378e+1	2.612073e-2	1	2.612073e-2	1.000000e+0	8	1.834710e-2	1.000000e+0	1.000000e+0	5.450453e+1	1.834710e-2	1	331	1.000000e+0	3.021148e-3	unnamed	PRPF31
GO Biological Process	GO:0006397	mRNA processing	9	3.227947e-2	1.000000e+0	1.000000e+0	3.097945e+1	3.227947e-2	1	3.227947e-2	1.000000e+0	9	2.261515e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	408	1.000000e+0	2.450980e-3	unnamed	PRPF31
GO Biological Process	GO:0034622	cellular macromolecular complex assembly	10	4.307981e-2	1.000000e+0	1.000000e+0	2.321273e+1	4.307981e-2	1	4.307981e-2	1.000000e+0	10	2.832437e-2	1.000000e+0	1.000000e+0	3.530528e+1	2.832437e-2	1	511	1.000000e+0	1.956947e-3	unnamed	PRPF31
GO Biological Process	GO:0016071	mRNA metabolic process	11	4.391612e-2	1.000000e+0	1.000000e+0	2.277068e+1	4.391612e-2	1	4.391612e-2	1.000000e+0	11	3.414445e-2	1.000000e+0	1.000000e+0	2.928734e+1	3.414445e-2	1	616	1.000000e+0	1.623377e-3	unnamed	PRPF31
GO Biological Process	GO:0006396	RNA processing	12	4.781684e-2	1.000000e+0	1.000000e+0	2.091314e+1	4.781684e-2	1	4.781684e-2	1.000000e+0	12	3.697134e-2	1.000000e+0	1.000000e+0	2.704798e+1	3.697134e-2	1	667	1.000000e+0	1.499250e-3	unnamed	PRPF31
GO Biological Process	GO:0065003	macromolecular complex assembly	13	8.650677e-2	1.000000e+0	1.000000e+0	1.155979e+1	8.650677e-2	1	8.650677e-2	1.000000e+0	13	5.548473e-2	1.000000e+0	1.000000e+0	1.802298e+1	5.548473e-2	1	1001	1.000000e+0	9.990010e-4	unnamed	PRPF31
GO Biological Process	GO:0043933	macromolecular complex subunit organization	14	1.093852e-1	1.000000e+0	1.000000e+0	9.142007e+0	1.093852e-1	1	1.093852e-1	1.000000e+0	14	7.089407e-2	1.000000e+0	1.000000e+0	1.410555e+1	7.089407e-2	1	1279	1.000000e+0	7.818608e-4	unnamed	PRPF31
GO Biological Process	GO:0022607	cellular component assembly	15	1.412864e-1	1.000000e+0	1.000000e+0	7.077823e+0	1.412864e-1	1	1.412864e-1	1.000000e+0	15	8.264509e-2	1.000000e+0	1.000000e+0	1.209993e+1	8.264509e-2	1	1491	1.000000e+0	6.706908e-4	unnamed	PRPF31
GO Biological Process	GO:0044085	cellular component biogenesis	16	1.485548e-1	1.000000e+0	1.000000e+0	6.731524e+0	1.485548e-1	1	1.485548e-1	1.000000e+0	16	9.046062e-2	1.000000e+0	1.000000e+0	1.105453e+1	9.046062e-2	1	1632	1.000000e+0	6.127451e-4	unnamed	PRPF31
GO Biological Process	GO:0016070	RNA metabolic process	17	2.686590e-1	1.000000e+0	1.000000e+0	3.722190e+0	2.686590e-1	1	2.686590e-1	1.000000e+0	17	1.760989e-1	1.000000e+0	1.000000e+0	5.678628e+0	1.760989e-1	1	3177	1.000000e+0	3.147624e-4	unnamed	PRPF31
GO Biological Process	GO:0010467	gene expression	18	2.836887e-1	1.000000e+0	1.000000e+0	3.524990e+0	2.836887e-1	1	2.836887e-1	1.000000e+0	18	1.901779e-1	1.000000e+0	1.000000e+0	5.258234e+0	1.901779e-1	1	3431	1.000000e+0	2.914602e-4	unnamed	PRPF31
GO Biological Process	GO:0090304	nucleic acid metabolic process	19	3.065231e-1	1.000000e+0	1.000000e+0	3.262397e+0	3.065231e-1	1	3.065231e-1	1.000000e+0	19	2.105759e-1	1.000000e+0	1.000000e+0	4.748881e+0	2.105759e-1	1	3799	1.000000e+0	2.632272e-4	unnamed	PRPF31
GO Biological Process	GO:0006139	nucleobase-containing compound metabolic process	20	3.530780e-1	1.000000e+0	1.000000e+0	2.832235e+0	3.530780e-1	1	3.530780e-1	1.000000e+0	22	2.484341e-1	1.000000e+0	1.000000e+0	4.025212e+0	2.484341e-1	1	4482	1.000000e+0	2.231147e-4	unnamed	PRPF31
GO Biological Process	GO:0046483	heterocycle metabolic process	21	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	23	2.580788e-1	1.000000e+0	1.000000e+0	3.874785e+0	2.580788e-1	1	4656	1.000000e+0	2.147766e-4	unnamed	PRPF31
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	22	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	24	2.587994e-1	1.000000e+0	1.000000e+0	3.863997e+0	2.587994e-1	1	4669	1.000000e+0	2.141786e-4	unnamed	PRPF31
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	23	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	25	2.694973e-1	1.000000e+0	1.000000e+0	3.710613e+0	2.694973e-1	1	4862	1.000000e+0	2.056767e-4	unnamed	PRPF31
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	24	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	26	2.708830e-1	1.000000e+0	1.000000e+0	3.691631e+0	2.708830e-1	1	4887	1.000000e+0	2.046245e-4	unnamed	PRPF31
GO Biological Process	GO:0016043	cellular component organization	25	3.831577e-1	1.000000e+0	1.000000e+0	2.609891e+0	3.831577e-1	1	3.831577e-1	1.000000e+0	20	2.231584e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	4026	1.000000e+0	2.483855e-4	unnamed	PRPF31
GO Biological Process	GO:0071840	cellular component organization or biogenesis	26	3.897194e-1	1.000000e+0	1.000000e+0	2.565949e+0	3.897194e-1	1	3.897194e-1	1.000000e+0	21	2.299762e-1	1.000000e+0	1.000000e+0	4.348277e+0	2.299762e-1	1	4149	1.000000e+0	2.410219e-4	unnamed	PRPF31
GO Biological Process	GO:0006807	nitrogen compound metabolic process	27	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	27	2.925004e-1	1.000000e+0	1.000000e+0	3.418799e+0	2.925004e-1	1	5277	1.000000e+0	1.895016e-4	unnamed	PRPF31
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	28	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	28	3.421651e-1	1.000000e+0	1.000000e+0	2.922566e+0	3.421651e-1	1	6173	1.000000e+0	1.619958e-4	unnamed	PRPF31
GO Biological Process	GO:0043170	macromolecule metabolic process	29	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	29	3.758661e-1	1.000000e+0	1.000000e+0	2.660522e+0	3.758661e-1	1	6781	1.000000e+0	1.474709e-4	unnamed	PRPF31
GO Biological Process	GO:0044237	cellular metabolic process	30	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	30	4.564049e-1	1.000000e+0	1.000000e+0	2.191037e+0	4.564049e-1	1	8234	1.000000e+0	1.214477e-4	unnamed	PRPF31
GO Biological Process	GO:0044238	primary metabolic process	31	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	31	4.608946e-1	1.000000e+0	1.000000e+0	2.169693e+0	4.608946e-1	1	8315	1.000000e+0	1.202646e-4	unnamed	PRPF31
GO Biological Process	GO:0071704	organic substance metabolic process	32	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	32	4.745857e-1	1.000000e+0	1.000000e+0	2.107101e+0	4.745857e-1	1	8562	1.000000e+0	1.167951e-4	unnamed	PRPF31
GO Biological Process	GO:0008152	metabolic process	33	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	33	5.097278e-1	1.000000e+0	1.000000e+0	1.961831e+0	5.097278e-1	1	9196	1.000000e+0	1.087429e-4	unnamed	PRPF31
GO Biological Process	GO:0009987	cellular process	34	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	34	7.487944e-1	1.000000e+0	1.000000e+0	1.335480e+0	7.487944e-1	1	13509	1.000000e+0	7.402472e-5	unnamed	PRPF31
GO Cellular Component	GO:0005690	U4atac snRNP	1	3.749979e-6	4.743723e-3	4.743723e-3	2.666681e+5	3.749979e-6	1	3.749979e-6	1.000000e+0	1	5.542930e-5	7.011806e-2	7.011806e-2	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	PRPF31
GO Cellular Component	GO:0005687	U4 snRNP	2	5.846892e-6	7.396318e-3	3.698159e-3	1.710310e+5	5.846892e-6	1	5.846892e-6	1.000000e+0	2	1.108586e-4	1.402361e-1	7.011806e-2	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	PRPF31
GO Cellular Component	GO:0005684	U2-type spliceosomal complex	3	5.257974e-5	6.651337e-2	2.217112e-2	1.901873e+4	5.257974e-5	1	5.257974e-5	1.000000e+0	3	1.662879e-4	2.103542e-1	7.011806e-2	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	PRPF31
GO Cellular Component	GO:0046540	U4/U6 x U5 tri-snRNP complex	4	1.321338e-4	1.671493e-1	4.178731e-2	7.568085e+3	1.321338e-4	1	1.321338e-4	1.000000e+0	4	2.217172e-4	2.804723e-1	7.011806e-2	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	PRPF31
GO Cellular Component	GO:0071339	MLL1 complex	5	1.537447e-3	1.000000e+0	3.889741e-1	6.504290e+2	1.537447e-3	1	1.537447e-3	1.000000e+0	5	1.552020e-3	1.000000e+0	3.926611e-1	6.443214e+2	1.552020e-3	1	28	1.000000e+0	3.571429e-2	unnamed	PRPF31
GO Cellular Component	GO:0030532	small nuclear ribonucleoprotein complex	6	1.818515e-3	1.000000e+0	3.834036e-1	5.498993e+2	1.818515e-3	1	1.818515e-3	1.000000e+0	8	2.106313e-3	1.000000e+0	3.330607e-1	4.747632e+2	2.106313e-3	1	38	1.000000e+0	2.631579e-2	unnamed	PRPF31
GO Cellular Component	GO:0015030	Cajal body	7	2.335127e-3	1.000000e+0	4.219908e-1	4.282422e+2	2.335127e-3	1	2.335127e-3	1.000000e+0	9	2.217172e-3	1.000000e+0	3.116358e-1	4.510250e+2	2.217172e-3	1	40	1.000000e+0	2.500000e-2	unnamed	PRPF31
GO Cellular Component	GO:0019013	viral nucleocapsid	8	3.058051e-3	1.000000e+0	4.835543e-1	3.270056e+2	3.058051e-3	1	3.058051e-3	1.000000e+0	6	1.940025e-3	1.000000e+0	4.090219e-1	5.154571e+2	1.940025e-3	1	35	1.000000e+0	2.857143e-2	unnamed	PRPF31
GO Cellular Component	GO:0019028	viral capsid	9	3.132108e-3	1.000000e+0	4.402352e-1	3.192738e+2	3.132108e-3	1	3.132108e-3	1.000000e+0	7	2.050884e-3	1.000000e+0	3.706240e-1	4.875946e+2	2.050884e-3	1	37	1.000000e+0	2.702703e-2	unnamed	PRPF31
GO Cellular Component	GO:0044423	virion part	10	3.452514e-3	1.000000e+0	4.367430e-1	2.896440e+2	3.452514e-3	1	3.452514e-3	1.000000e+0	10	2.383460e-3	1.000000e+0	3.015077e-1	4.195581e+2	2.383460e-3	1	43	1.000000e+0	2.325581e-2	unnamed	PRPF31
GO Cellular Component	GO:0035097	histone methyltransferase complex	11	5.214525e-3	1.000000e+0	5.996704e-1	1.917720e+2	5.214525e-3	1	5.214525e-3	1.000000e+0	11	3.547475e-3	1.000000e+0	4.079596e-1	2.818906e+2	3.547475e-3	1	64	1.000000e+0	1.562500e-2	unnamed	PRPF31
GO Cellular Component	GO:0034708	methyltransferase complex	12	5.253517e-3	1.000000e+0	5.538083e-1	1.903487e+2	5.253517e-3	1	5.253517e-3	1.000000e+0	12	3.658334e-3	1.000000e+0	3.856494e-1	2.733485e+2	3.658334e-3	1	66	1.000000e+0	1.515152e-2	unnamed	PRPF31
GO Cellular Component	GO:0005681	spliceosomal complex	13	1.119029e-2	1.000000e+0	1.000000e+0	8.936318e+1	1.119029e-2	1	1.119029e-2	1.000000e+0	13	8.536112e-3	1.000000e+0	8.306294e-1	1.171494e+2	8.536112e-3	1	154	1.000000e+0	6.493506e-3	unnamed	PRPF31
GO Cellular Component	GO:0016607	nuclear speck	14	1.462650e-2	1.000000e+0	1.000000e+0	6.836907e+1	1.462650e-2	1	1.462650e-2	1.000000e+0	14	8.979547e-3	1.000000e+0	8.113662e-1	1.113642e+2	8.979547e-3	1	162	1.000000e+0	6.172840e-3	unnamed	PRPF31
GO Cellular Component	GO:0016604	nuclear body	15	2.621946e-2	1.000000e+0	1.000000e+0	3.813961e+1	2.621946e-2	1	2.621946e-2	1.000000e+0	15	1.657336e-2	1.000000e+0	1.000000e+0	6.033779e+1	1.657336e-2	1	299	1.000000e+0	3.344482e-3	unnamed	PRPF31
GO Cellular Component	GO:0030529	ribonucleoprotein complex	16	4.087608e-2	1.000000e+0	1.000000e+0	2.446418e+1	4.087608e-2	1	4.087608e-2	1.000000e+0	16	3.492046e-2	1.000000e+0	1.000000e+0	2.863651e+1	3.492046e-2	1	630	1.000000e+0	1.587302e-3	unnamed	PRPF31
GO Cellular Component	GO:0044451	nucleoplasm part	17	5.637067e-2	1.000000e+0	1.000000e+0	1.773972e+1	5.637067e-2	1	5.637067e-2	1.000000e+0	17	3.541932e-2	1.000000e+0	1.000000e+0	2.823318e+1	3.541932e-2	1	639	1.000000e+0	1.564945e-3	unnamed	PRPF31
GO Cellular Component	GO:0005654	nucleoplasm	18	1.212700e-1	1.000000e+0	1.000000e+0	8.246060e+0	1.212700e-1	1	1.212700e-1	1.000000e+0	18	7.870961e-2	1.000000e+0	1.000000e+0	1.270493e+1	7.870961e-2	1	1420	1.000000e+0	7.042254e-4	unnamed	PRPF31
GO Cellular Component	GO:0031981	nuclear lumen	19	1.748307e-1	1.000000e+0	1.000000e+0	5.719819e+0	1.748307e-1	1	1.748307e-1	1.000000e+0	19	1.154038e-1	1.000000e+0	1.000000e+0	8.665226e+0	1.154038e-1	1	2082	1.000000e+0	4.803074e-4	unnamed	PRPF31
GO Cellular Component	GO:0044428	nuclear part	20	2.070089e-1	1.000000e+0	1.000000e+0	4.830709e+0	2.070089e-1	1	2.070089e-1	1.000000e+0	20	1.370212e-1	1.000000e+0	1.000000e+0	7.298139e+0	1.370212e-1	1	2472	1.000000e+0	4.045307e-4	unnamed	PRPF31
GO Cellular Component	GO:0070013	intracellular organelle lumen	21	2.178720e-1	1.000000e+0	1.000000e+0	4.589852e+0	2.178720e-1	1	2.178720e-1	1.000000e+0	21	1.491048e-1	1.000000e+0	1.000000e+0	6.706691e+0	1.491048e-1	1	2690	1.000000e+0	3.717472e-4	unnamed	PRPF31
GO Cellular Component	GO:0043233	organelle lumen	22	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	22	1.524306e-1	1.000000e+0	1.000000e+0	6.560364e+0	1.524306e-1	1	2750	1.000000e+0	3.636364e-4	unnamed	PRPF31
GO Cellular Component	GO:0031974	membrane-enclosed lumen	23	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	23	1.552020e-1	1.000000e+0	1.000000e+0	6.443214e+0	1.552020e-1	1	2800	1.000000e+0	3.571429e-4	unnamed	PRPF31
GO Cellular Component	GO:0043234	protein complex	24	3.027166e-1	1.000000e+0	1.000000e+0	3.303419e+0	3.027166e-1	1	3.027166e-1	1.000000e+0	24	2.018735e-1	1.000000e+0	1.000000e+0	4.953597e+0	2.018735e-1	1	3642	1.000000e+0	2.745744e-4	unnamed	PRPF31
GO Cellular Component	GO:0032991	macromolecular complex	25	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	25	2.340225e-1	1.000000e+0	1.000000e+0	4.273093e+0	2.340225e-1	1	4222	1.000000e+0	2.368546e-4	unnamed	PRPF31
GO Cellular Component	GO:0044446	intracellular organelle part	26	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	27	3.595144e-1	1.000000e+0	1.000000e+0	2.781529e+0	3.595144e-1	1	6486	1.000000e+0	1.541782e-4	unnamed	PRPF31
GO Cellular Component	GO:0005634	nucleus	27	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	26	3.366776e-1	1.000000e+0	1.000000e+0	2.970201e+0	3.366776e-1	1	6074	1.000000e+0	1.646362e-4	unnamed	PRPF31
GO Cellular Component	GO:0044422	organelle part	28	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	28	3.657225e-1	1.000000e+0	1.000000e+0	2.734313e+0	3.657225e-1	1	6598	1.000000e+0	1.515611e-4	unnamed	PRPF31
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	29	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	29	5.549582e-1	1.000000e+0	1.000000e+0	1.801938e+0	5.549582e-1	1	10012	1.000000e+0	9.988014e-5	unnamed	PRPF31
GO Cellular Component	GO:0043227	membrane-bounded organelle	30	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	30	5.568427e-1	1.000000e+0	1.000000e+0	1.795839e+0	5.568427e-1	1	10046	1.000000e+0	9.954211e-5	unnamed	PRPF31
GO Cellular Component	GO:0043229	intracellular organelle	31	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	31	6.092789e-1	1.000000e+0	1.000000e+0	1.641285e+0	6.092789e-1	1	10992	1.000000e+0	9.097525e-5	unnamed	PRPF31
GO Cellular Component	GO:0043226	organelle	32	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	32	6.110526e-1	1.000000e+0	1.000000e+0	1.636520e+0	6.110526e-1	1	11024	1.000000e+0	9.071118e-5	unnamed	PRPF31
GO Cellular Component	GO:0044424	intracellular part	33	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	33	6.971897e-1	1.000000e+0	1.000000e+0	1.434330e+0	6.971897e-1	1	12578	1.000000e+0	7.950390e-5	unnamed	PRPF31
GO Cellular Component	GO:0005622	intracellular	34	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	34	7.066127e-1	1.000000e+0	1.000000e+0	1.415202e+0	7.066127e-1	1	12748	1.000000e+0	7.844368e-5	unnamed	PRPF31
GO Cellular Component	GO:0044464	cell part	35	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	35	8.202982e-1	1.000000e+0	1.000000e+0	1.219069e+0	8.202982e-1	1	14799	1.000000e+0	6.757213e-5	unnamed	PRPF31
GO Cellular Component	GO:0005623	cell	36	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	36	8.203536e-1	1.000000e+0	1.000000e+0	1.218986e+0	8.203536e-1	1	14800	1.000000e+0	6.756757e-5	unnamed	PRPF31
Mouse Phenotype	MP:0001326	retinal degeneration	1	8.609326e-3	1.000000e+0	1.000000e+0	1.161531e+2	8.609326e-3	1	8.609326e-3	1.000000e+0	1	5.321213e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	96	1.000000e+0	1.041667e-2	unnamed	PRPF31
Mouse Phenotype	MP:0005201	abnormal retinal pigment epithelium morphology	2	1.749149e-2	1.000000e+0	1.000000e+0	5.717065e+1	1.749149e-2	1	1.749149e-2	1.000000e+0	2	6.984092e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	126	1.000000e+0	7.936508e-3	unnamed	PRPF31
Mouse Phenotype	MP:0005200	abnormal eye pigment epithelium morphology	3	1.901698e-2	1.000000e+0	1.000000e+0	5.258458e+1	1.901698e-2	1	1.901698e-2	1.000000e+0	3	7.482955e-3	1.000000e+0	1.000000e+0	1.336370e+2	7.482955e-3	1	135	1.000000e+0	7.407407e-3	unnamed	PRPF31
Mouse Phenotype	MP:0001324	abnormal eye pigmentation	4	2.231924e-2	1.000000e+0	1.000000e+0	4.480439e+1	2.231924e-2	1	2.231924e-2	1.000000e+0	5	8.702400e-3	1.000000e+0	1.000000e+0	1.149108e+2	8.702400e-3	1	157	1.000000e+0	6.369427e-3	unnamed	PRPF31
Mouse Phenotype	MP:0011100	complete preweaning lethality	5	2.236533e-2	1.000000e+0	1.000000e+0	4.471206e+1	2.236533e-2	1	2.236533e-2	1.000000e+0	4	8.258966e-3	1.000000e+0	1.000000e+0	1.210805e+2	8.258966e-3	1	149	1.000000e+0	6.711409e-3	unnamed	PRPF31
Mouse Phenotype	MP:0009389	abnormal extracutaneous pigmentation	6	2.290596e-2	1.000000e+0	1.000000e+0	4.365676e+1	2.290596e-2	1	2.290596e-2	1.000000e+0	6	8.979547e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	162	1.000000e+0	6.172840e-3	unnamed	PRPF31
Mouse Phenotype	MP:0011092	complete embryonic lethality	7	4.260939e-2	1.000000e+0	1.000000e+0	2.346900e+1	4.260939e-2	1	4.260939e-2	1.000000e+0	7	1.940025e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	350	1.000000e+0	2.857143e-3	unnamed	PRPF31
Mouse Phenotype	MP:0001186	pigmentation phenotype	8	4.655148e-2	1.000000e+0	1.000000e+0	2.148159e+1	4.655148e-2	1	4.655148e-2	1.000000e+0	9	2.012084e-2	1.000000e+0	1.000000e+0	4.969972e+1	2.012084e-2	1	363	1.000000e+0	2.754821e-3	unnamed	PRPF31
Mouse Phenotype	MP:0003727	abnormal retinal layer morphology	9	4.893408e-2	1.000000e+0	1.000000e+0	2.043566e+1	4.893408e-2	1	4.893408e-2	1.000000e+0	8	1.973283e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	356	1.000000e+0	2.808989e-3	unnamed	PRPF31
Mouse Phenotype	MP:0001325	abnormal retina morphology	10	6.912854e-2	1.000000e+0	1.000000e+0	1.446580e+1	6.912854e-2	1	6.912854e-2	1.000000e+0	10	2.865695e-2	1.000000e+0	1.000000e+0	3.489555e+1	2.865695e-2	1	517	1.000000e+0	1.934236e-3	unnamed	PRPF31
Mouse Phenotype	MP:0002864	abnormal ocular fundus morphology	11	7.069037e-2	1.000000e+0	1.000000e+0	1.414620e+1	7.069037e-2	1	7.069037e-2	1.000000e+0	11	2.937753e-2	1.000000e+0	1.000000e+0	3.403962e+1	2.937753e-2	1	530	1.000000e+0	1.886792e-3	unnamed	PRPF31
Mouse Phenotype	MP:0005195	abnormal posterior eye segment morphology	12	7.618498e-2	1.000000e+0	1.000000e+0	1.312595e+1	7.618498e-2	1	7.618498e-2	1.000000e+0	12	3.181642e-2	1.000000e+0	1.000000e+0	3.143031e+1	3.181642e-2	1	574	1.000000e+0	1.742160e-3	unnamed	PRPF31
Mouse Phenotype	MP:0002092	abnormal eye morphology	13	1.428440e-1	1.000000e+0	1.000000e+0	7.000642e+0	1.428440e-1	1	1.428440e-1	1.000000e+0	13	6.130481e-2	1.000000e+0	1.000000e+0	1.631193e+1	6.130481e-2	1	1106	1.000000e+0	9.041591e-4	unnamed	PRPF31
Mouse Phenotype	MP:0005391	vision/eye phenotype	14	1.504147e-1	1.000000e+0	1.000000e+0	6.648285e+0	1.504147e-1	1	1.504147e-1	1.000000e+0	14	6.557286e-2	1.000000e+0	1.000000e+0	1.525021e+1	6.557286e-2	1	1183	1.000000e+0	8.453085e-4	unnamed	PRPF31
Mouse Phenotype	MP:0008762	embryonic lethality	15	1.587123e-1	1.000000e+0	1.000000e+0	6.300711e+0	1.587123e-1	1	1.587123e-1	1.000000e+0	15	8.719029e-2	1.000000e+0	1.000000e+0	1.146917e+1	8.719029e-2	1	1573	1.000000e+0	6.357279e-4	unnamed	PRPF31
Mouse Phenotype	MP:0002080	prenatal lethality	16	2.134127e-1	1.000000e+0	1.000000e+0	4.685758e+0	2.134127e-1	1	2.134127e-1	1.000000e+0	16	1.131312e-1	1.000000e+0	1.000000e+0	8.839294e+0	1.131312e-1	1	2041	1.000000e+0	4.899559e-4	unnamed	PRPF31
Mouse Phenotype	MP:0010770	preweaning lethality	17	3.585301e-1	1.000000e+0	1.000000e+0	2.789166e+0	3.585301e-1	1	3.585301e-1	1.000000e+0	17	1.806441e-1	1.000000e+0	1.000000e+0	5.535747e+0	1.806441e-1	1	3259	1.000000e+0	3.068426e-4	unnamed	PRPF31
Mouse Phenotype	MP:0010769	abnormal survival	18	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	18	2.093565e-1	1.000000e+0	1.000000e+0	4.776542e+0	2.093565e-1	1	3777	1.000000e+0	2.647604e-4	unnamed	PRPF31
Mouse Phenotype	MP:0010768	mortality/aging	19	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	19	2.242669e-1	1.000000e+0	1.000000e+0	4.458972e+0	2.242669e-1	1	4046	1.000000e+0	2.471577e-4	unnamed	PRPF31
Mouse Phenotype	MP:0000001	mammalian phenotype	20	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	20	4.170501e-1	1.000000e+0	1.000000e+0	2.397794e+0	4.170501e-1	1	7524	1.000000e+0	1.329080e-4	unnamed	PRPF31
Human Phenotype	HP:0100689	Decreased corneal thickness	1	7.132799e-3	1.000000e+0	1.000000e+0	1.401974e+2	7.132799e-3	1	7.132799e-3	1.000000e+0	2	4.434344e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	80	1.000000e+0	1.250000e-2	unnamed	PRPF31
Human Phenotype	HP:0000842	Hyperinsulinemia	2	7.194569e-3	1.000000e+0	1.000000e+0	1.389937e+2	7.194569e-3	1	7.194569e-3	1.000000e+0	4	4.545203e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	82	1.000000e+0	1.219512e-2	unnamed	PRPF31
Human Phenotype	HP:0011486	Abnormality of corneal thickness	3	7.410583e-3	1.000000e+0	1.000000e+0	1.349422e+2	7.410583e-3	1	7.410583e-3	1.000000e+0	3	4.489773e-3	1.000000e+0	1.000000e+0	2.227284e+2	4.489773e-3	1	81	1.000000e+0	1.234568e-2	unnamed	PRPF31
Human Phenotype	HP:0008046	Abnormality of the retinal vasculature	4	7.424132e-3	1.000000e+0	1.000000e+0	1.346959e+2	7.424132e-3	1	7.424132e-3	1.000000e+0	6	5.764647e-3	1.000000e+0	1.000000e+0	1.734712e+2	5.764647e-3	1	104	1.000000e+0	9.615385e-3	unnamed	PRPF31
Human Phenotype	HP:0008047	Abnormality of the vasculature of the eye	5	7.843598e-3	1.000000e+0	1.000000e+0	1.274925e+2	7.843598e-3	1	7.843598e-3	1.000000e+0	8	6.152652e-3	1.000000e+0	1.000000e+0	1.625315e+2	6.152652e-3	1	111	1.000000e+0	9.009009e-3	unnamed	PRPF31
Human Phenotype	HP:0005978	Type II diabetes mellitus	6	7.930955e-3	1.000000e+0	1.000000e+0	1.260882e+2	7.930955e-3	1	7.930955e-3	1.000000e+0	5	4.988637e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	90	1.000000e+0	1.111111e-2	unnamed	PRPF31
Human Phenotype	HP:0000510	Retinitis pigmentosa	7	8.274862e-3	1.000000e+0	1.000000e+0	1.208479e+2	8.274862e-3	1	8.274862e-3	1.000000e+0	1	4.212627e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	76	1.000000e+0	1.315789e-2	unnamed	PRPF31
Human Phenotype	HP:0000662	Night blindness	8	9.351489e-3	1.000000e+0	1.000000e+0	1.069348e+2	9.351489e-3	1	9.351489e-3	1.000000e+0	10	6.596087e-3	1.000000e+0	1.000000e+0	1.516050e+2	6.596087e-3	1	119	1.000000e+0	8.403361e-3	unnamed	PRPF31
Human Phenotype	HP:0000987	Atypical scarring of skin	9	9.492875e-3	1.000000e+0	1.000000e+0	1.053422e+2	9.492875e-3	1	9.492875e-3	1.000000e+0	7	5.820076e-3	1.000000e+0	1.000000e+0	1.718190e+2	5.820076e-3	1	105	1.000000e+0	9.523810e-3	unnamed	PRPF31
Human Phenotype	HP:0100699	Scarring	10	9.917120e-3	1.000000e+0	1.000000e+0	1.008357e+2	9.917120e-3	1	9.917120e-3	1.000000e+0	8	6.152652e-3	1.000000e+0	1.000000e+0	1.625315e+2	6.152652e-3	1	111	1.000000e+0	9.009009e-3	unnamed	PRPF31
Human Phenotype	HP:0000613	Photophobia	11	1.130566e-2	1.000000e+0	1.000000e+0	8.845131e+1	1.130566e-2	1	1.130566e-2	1.000000e+0	11	7.039521e-3	1.000000e+0	1.000000e+0	1.420551e+2	7.039521e-3	1	127	1.000000e+0	7.874016e-3	unnamed	PRPF31
Human Phenotype	HP:0000512	Abnormal electroretinogram	12	1.139741e-2	1.000000e+0	1.000000e+0	8.773922e+1	1.139741e-2	1	1.139741e-2	1.000000e+0	11	7.039521e-3	1.000000e+0	1.000000e+0	1.420551e+2	7.039521e-3	1	127	1.000000e+0	7.874016e-3	unnamed	PRPF31
Human Phenotype	HP:0000597	Ophthalmoparesis	13	1.196580e-2	1.000000e+0	1.000000e+0	8.357152e+1	1.196580e-2	1	1.196580e-2	1.000000e+0	16	8.369824e-3	1.000000e+0	1.000000e+0	1.194768e+2	8.369824e-3	1	151	1.000000e+0	6.622517e-3	unnamed	PRPF31
Human Phenotype	HP:0003117	Abnormality of circulating hormone level	14	1.372152e-2	1.000000e+0	1.000000e+0	7.287820e+1	1.372152e-2	1	1.372152e-2	1.000000e+0	13	7.205809e-3	1.000000e+0	1.000000e+0	1.387769e+2	7.205809e-3	1	130	1.000000e+0	7.692308e-3	unnamed	PRPF31
Human Phenotype	HP:0000819	Diabetes mellitus	15	1.619858e-2	1.000000e+0	1.000000e+0	6.173382e+1	1.619858e-2	1	1.619858e-2	1.000000e+0	17	9.921845e-3	1.000000e+0	1.000000e+0	1.007877e+2	9.921845e-3	1	179	1.000000e+0	5.586592e-3	unnamed	PRPF31
Human Phenotype	HP:0000405	Conductive hearing impairment	16	1.627022e-2	1.000000e+0	1.000000e+0	6.146199e+1	1.627022e-2	1	1.627022e-2	1.000000e+0	14	7.704673e-3	1.000000e+0	1.000000e+0	1.297914e+2	7.704673e-3	1	139	1.000000e+0	7.194245e-3	unnamed	PRPF31
Human Phenotype	HP:0011452	Functional abnormality of the middle ear	17	1.678248e-2	1.000000e+0	1.000000e+0	5.958595e+1	1.678248e-2	1	1.678248e-2	1.000000e+0	15	7.815531e-3	1.000000e+0	1.000000e+0	1.279504e+2	7.815531e-3	1	141	1.000000e+0	7.092199e-3	unnamed	PRPF31
Human Phenotype	HP:0007703	Abnormal retinal pigmentation	18	1.943895e-2	1.000000e+0	1.000000e+0	5.144311e+1	1.943895e-2	1	1.943895e-2	1.000000e+0	23	1.119672e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	202	1.000000e+0	4.950495e-3	unnamed	PRPF31
Human Phenotype	HP:0000501	Glaucoma	19	2.135653e-2	1.000000e+0	1.000000e+0	4.682408e+1	2.135653e-2	1	2.135653e-2	1.000000e+0	21	1.053157e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	190	1.000000e+0	5.263158e-3	unnamed	PRPF31
Human Phenotype	HP:0008051	Abnormality of the retinal pigment epithelium	20	2.142508e-2	1.000000e+0	1.000000e+0	4.667427e+1	2.142508e-2	1	2.142508e-2	1.000000e+0	24	1.202816e-2	1.000000e+0	1.000000e+0	8.313825e+1	1.202816e-2	1	217	1.000000e+0	4.608295e-3	unnamed	PRPF31
Human Phenotype	HP:0001513	Obesity	21	2.334050e-2	1.000000e+0	1.000000e+0	4.284398e+1	2.334050e-2	1	2.334050e-2	1.000000e+0	18	9.977274e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	180	1.000000e+0	5.555556e-3	unnamed	PRPF31
Human Phenotype	HP:0000370	Abnormality of the middle ear	22	2.356312e-2	1.000000e+0	1.000000e+0	4.243920e+1	2.356312e-2	1	2.356312e-2	1.000000e+0	26	1.285960e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	232	1.000000e+0	4.310345e-3	unnamed	PRPF31
Human Phenotype	HP:0004324	Increased body weight	23	2.416288e-2	1.000000e+0	1.000000e+0	4.138580e+1	2.416288e-2	1	2.416288e-2	1.000000e+0	20	1.047614e-2	1.000000e+0	1.000000e+0	9.545503e+1	1.047614e-2	1	189	1.000000e+0	5.291005e-3	unnamed	PRPF31
Human Phenotype	HP:0000431	Wide nasal bridge	24	2.525879e-2	1.000000e+0	1.000000e+0	3.959018e+1	2.525879e-2	1	2.525879e-2	1.000000e+0	19	1.019899e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	184	1.000000e+0	5.434783e-3	unnamed	PRPF31
Human Phenotype	HP:0011014	Abnormal glucose homeostasis	25	2.584232e-2	1.000000e+0	1.000000e+0	3.869621e+1	2.584232e-2	1	2.584232e-2	1.000000e+0	31	1.646250e-2	1.000000e+0	1.000000e+0	6.074411e+1	1.646250e-2	1	297	1.000000e+0	3.367003e-3	unnamed	PRPF31
Human Phenotype	HP:0000463	Anteverted nares	26	2.779733e-2	1.000000e+0	1.000000e+0	3.597468e+1	2.779733e-2	1	2.779733e-2	1.000000e+0	26	1.285960e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	232	1.000000e+0	4.310345e-3	unnamed	PRPF31
Human Phenotype	HP:0001347	Hyperreflexia	27	2.789222e-2	1.000000e+0	1.000000e+0	3.585229e+1	2.789222e-2	1	2.789222e-2	1.000000e+0	34	1.729394e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	312	1.000000e+0	3.205128e-3	unnamed	PRPF31
Human Phenotype	HP:0008736	Hypoplasia of penis	28	2.837320e-2	1.000000e+0	1.000000e+0	3.524452e+1	2.837320e-2	1	2.837320e-2	1.000000e+0	22	1.108586e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	200	1.000000e+0	5.000000e-3	unnamed	PRPF31
Human Phenotype	HP:0005288	Abnormality of the nares	29	2.897002e-2	1.000000e+0	1.000000e+0	3.451844e+1	2.897002e-2	1	2.897002e-2	1.000000e+0	29	1.335846e-2	1.000000e+0	1.000000e+0	7.485892e+1	1.335846e-2	1	241	1.000000e+0	4.149378e-3	unnamed	PRPF31
Human Phenotype	HP:0011013	Abnormality of carbohydrate metabolism/homeostasis	30	2.907742e-2	1.000000e+0	1.000000e+0	3.439095e+1	2.907742e-2	1	2.907742e-2	1.000000e+0	36	1.917854e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	346	1.000000e+0	2.890173e-3	unnamed	PRPF31
Human Phenotype	HP:0000648	Optic atrophy	31	2.952567e-2	1.000000e+0	1.000000e+0	3.386883e+1	2.952567e-2	1	2.952567e-2	1.000000e+0	32	1.701680e-2	1.000000e+0	1.000000e+0	5.876547e+1	1.701680e-2	1	307	1.000000e+0	3.257329e-3	unnamed	PRPF31
Human Phenotype	HP:0000050	Hypoplastic genitalia	32	3.012583e-2	1.000000e+0	1.000000e+0	3.319411e+1	3.012583e-2	1	3.012583e-2	1.000000e+0	25	1.252702e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	226	1.000000e+0	4.424779e-3	unnamed	PRPF31
Human Phenotype	HP:0003241	Genital hypoplasia	33	3.063069e-2	1.000000e+0	1.000000e+0	3.264699e+1	3.063069e-2	1	3.063069e-2	1.000000e+0	28	1.297046e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	234	1.000000e+0	4.273504e-3	unnamed	PRPF31
Human Phenotype	HP:0000587	Abnormality of the optic nerve	34	3.320424e-2	1.000000e+0	1.000000e+0	3.011663e+1	3.320424e-2	1	3.320424e-2	1.000000e+0	37	1.967740e-2	1.000000e+0	1.000000e+0	5.081972e+1	1.967740e-2	1	355	1.000000e+0	2.816901e-3	unnamed	PRPF31
Human Phenotype	HP:0000429	Abnormality of the nasal alae	35	3.557102e-2	1.000000e+0	1.000000e+0	2.811277e+1	3.557102e-2	1	3.557102e-2	1.000000e+0	30	1.507677e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	272	1.000000e+0	3.676471e-3	unnamed	PRPF31
Human Phenotype	HP:0000481	Abnormality of the cornea	36	3.847321e-2	1.000000e+0	1.000000e+0	2.599211e+1	3.847321e-2	1	3.847321e-2	1.000000e+0	38	2.017627e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	364	1.000000e+0	2.747253e-3	unnamed	PRPF31
Human Phenotype	HP:0010938	Abnormality of the external nose	37	3.964107e-2	1.000000e+0	1.000000e+0	2.522636e+1	3.964107e-2	1	3.964107e-2	1.000000e+0	33	1.723851e-2	1.000000e+0	1.000000e+0	5.800965e+1	1.723851e-2	1	311	1.000000e+0	3.215434e-3	unnamed	PRPF31
Human Phenotype	HP:0000518	Cataract	38	3.983177e-2	1.000000e+0	1.000000e+0	2.510559e+1	3.983177e-2	1	3.983177e-2	1.000000e+0	39	2.222715e-2	1.000000e+0	1.000000e+0	4.499002e+1	2.222715e-2	1	401	1.000000e+0	2.493766e-3	unnamed	PRPF31
Human Phenotype	HP:0000517	Abnormality of the lens	39	4.100359e-2	1.000000e+0	1.000000e+0	2.438811e+1	4.100359e-2	1	4.100359e-2	1.000000e+0	41	2.294773e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	414	1.000000e+0	2.415459e-3	unnamed	PRPF31
Human Phenotype	HP:0000479	Abnormality of the retina	40	4.191016e-2	1.000000e+0	1.000000e+0	2.386056e+1	4.191016e-2	1	4.191016e-2	1.000000e+0	45	2.444432e-2	1.000000e+0	1.000000e+0	4.090930e+1	2.444432e-2	1	441	1.000000e+0	2.267574e-3	unnamed	PRPF31
Human Phenotype	HP:0000036	Abnormality of the penis	41	4.249983e-2	1.000000e+0	1.000000e+0	2.352951e+1	4.249983e-2	1	4.249983e-2	1.000000e+0	35	1.834710e-2	1.000000e+0	1.000000e+0	5.450453e+1	1.834710e-2	1	331	1.000000e+0	3.021148e-3	unnamed	PRPF31
Human Phenotype	HP:0002597	Abnormality of the vasculature	42	4.289777e-2	1.000000e+0	1.000000e+0	2.331124e+1	4.289777e-2	1	4.289777e-2	1.000000e+0	50	2.544205e-2	1.000000e+0	1.000000e+0	3.930501e+1	2.544205e-2	1	459	1.000000e+0	2.178649e-3	unnamed	PRPF31
Human Phenotype	HP:0000505	Visual impairment	43	4.619257e-2	1.000000e+0	1.000000e+0	2.164850e+1	4.619257e-2	1	4.619257e-2	1.000000e+0	46	2.466604e-2	1.000000e+0	1.000000e+0	4.054157e+1	2.466604e-2	1	445	1.000000e+0	2.247191e-3	unnamed	PRPF31
Human Phenotype	HP:0000407	Sensorineural hearing impairment	44	4.795301e-2	1.000000e+0	1.000000e+0	2.085375e+1	4.795301e-2	1	4.795301e-2	1.000000e+0	43	2.405632e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	434	1.000000e+0	2.304147e-3	unnamed	PRPF31
Human Phenotype	HP:0000504	Abnormality of vision	45	4.984025e-2	1.000000e+0	1.000000e+0	2.006411e+1	4.984025e-2	1	4.984025e-2	1.000000e+0	54	2.743750e-2	1.000000e+0	1.000000e+0	3.644646e+1	2.743750e-2	1	495	1.000000e+0	2.020202e-3	unnamed	PRPF31
Human Phenotype	HP:0011389	Functional abnormality of the inner ear	46	5.010074e-2	1.000000e+0	1.000000e+0	1.995978e+1	5.010074e-2	1	5.010074e-2	1.000000e+0	47	2.499861e-2	1.000000e+0	1.000000e+0	4.000222e+1	2.499861e-2	1	451	1.000000e+0	2.217295e-3	unnamed	PRPF31
Human Phenotype	HP:0000359	Abnormality of the inner ear	47	5.043815e-2	1.000000e+0	1.000000e+0	1.982626e+1	5.043815e-2	1	5.043815e-2	1.000000e+0	49	2.522033e-2	1.000000e+0	1.000000e+0	3.965055e+1	2.522033e-2	1	455	1.000000e+0	2.197802e-3	unnamed	PRPF31
Human Phenotype	HP:0000035	Abnormality of the testis	48	5.101368e-2	1.000000e+0	1.000000e+0	1.960258e+1	5.101368e-2	1	5.101368e-2	1.000000e+0	42	2.350202e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	424	1.000000e+0	2.358491e-3	unnamed	PRPF31
Human Phenotype	HP:0000639	Nystagmus	49	5.150322e-2	1.000000e+0	1.000000e+0	1.941626e+1	5.150322e-2	1	5.150322e-2	1.000000e+0	52	2.682778e-2	1.000000e+0	1.000000e+0	3.727479e+1	2.682778e-2	1	484	1.000000e+0	2.066116e-3	unnamed	PRPF31
Human Phenotype	HP:0000022	Abnormality of male internal genitalia	50	5.264829e-2	1.000000e+0	1.000000e+0	1.899397e+1	5.264829e-2	1	5.264829e-2	1.000000e+0	44	2.416717e-2	1.000000e+0	1.000000e+0	4.137844e+1	2.416717e-2	1	436	1.000000e+0	2.293578e-3	unnamed	PRPF31
Human Phenotype	HP:0000422	Abnormality of the nasal bridge	51	5.330993e-2	1.000000e+0	1.000000e+0	1.875823e+1	5.330993e-2	1	5.330993e-2	1.000000e+0	40	2.283687e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	412	1.000000e+0	2.427184e-3	unnamed	PRPF31
Human Phenotype	HP:0005105	Abnormal nasal morphology	52	5.425388e-2	1.000000e+0	1.000000e+0	1.843186e+1	5.425388e-2	1	5.425388e-2	1.000000e+0	48	2.505404e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	452	1.000000e+0	2.212389e-3	unnamed	PRPF31
Human Phenotype	HP:0000496	Abnormality of eye movement	53	5.789715e-2	1.000000e+0	1.000000e+0	1.727201e+1	5.789715e-2	1	5.789715e-2	1.000000e+0	57	3.142841e-2	1.000000e+0	1.000000e+0	3.181834e+1	3.142841e-2	1	567	1.000000e+0	1.763668e-3	unnamed	PRPF31
Human Phenotype	HP:0000818	Abnormality of the endocrine system	54	5.830630e-2	1.000000e+0	1.000000e+0	1.715081e+1	5.830630e-2	1	5.830630e-2	1.000000e+0	59	3.198271e-2	1.000000e+0	1.000000e+0	3.126690e+1	3.198271e-2	1	577	1.000000e+0	1.733102e-3	unnamed	PRPF31
Human Phenotype	HP:0007256	Abnormality of pyramidal motor function	55	5.852599e-2	1.000000e+0	1.000000e+0	1.708643e+1	5.852599e-2	1	5.852599e-2	1.000000e+0	60	3.286957e-2	1.000000e+0	1.000000e+0	3.042327e+1	3.286957e-2	1	593	1.000000e+0	1.686341e-3	unnamed	PRPF31
Human Phenotype	HP:0000032	Abnormality of male external genitalia	56	5.856997e-2	1.000000e+0	1.000000e+0	1.707359e+1	5.856997e-2	1	5.856997e-2	1.000000e+0	51	2.638435e-2	1.000000e+0	1.000000e+0	3.790126e+1	2.638435e-2	1	476	1.000000e+0	2.100840e-3	unnamed	PRPF31
Human Phenotype	HP:0002062	Abnormality of the pyramidal tracts	57	5.873395e-2	1.000000e+0	1.000000e+0	1.702593e+1	5.873395e-2	1	5.873395e-2	1.000000e+0	61	3.303586e-2	1.000000e+0	1.000000e+0	3.027013e+1	3.303586e-2	1	596	1.000000e+0	1.677852e-3	unnamed	PRPF31
Human Phenotype	HP:0001098	Abnormality of the fundus	58	5.873513e-2	1.000000e+0	1.000000e+0	1.702559e+1	5.873513e-2	1	5.873513e-2	1.000000e+0	61	3.303586e-2	1.000000e+0	1.000000e+0	3.027013e+1	3.303586e-2	1	596	1.000000e+0	1.677852e-3	unnamed	PRPF31
Human Phenotype	HP:0004329	Abnormality of the posterior segment of the eye	59	5.909903e-2	1.000000e+0	1.000000e+0	1.692075e+1	5.909903e-2	1	5.909903e-2	1.000000e+0	63	3.325758e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	600	1.000000e+0	1.666667e-3	unnamed	PRPF31
Human Phenotype	HP:0000811	Abnormal external genitalia	60	5.948677e-2	1.000000e+0	1.000000e+0	1.681046e+1	5.948677e-2	1	5.948677e-2	1.000000e+0	53	2.704950e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	488	1.000000e+0	2.049180e-3	unnamed	PRPF31
Human Phenotype	HP:0000708	Behavioural/Psychiatric Abnormality	61	6.042589e-2	1.000000e+0	1.000000e+0	1.654920e+1	6.042589e-2	1	6.042589e-2	1.000000e+0	57	3.142841e-2	1.000000e+0	1.000000e+0	3.181834e+1	3.142841e-2	1	567	1.000000e+0	1.763668e-3	unnamed	PRPF31
Human Phenotype	HP:0010461	Abnormality of the male genitalia	62	6.153041e-2	1.000000e+0	1.000000e+0	1.625213e+1	6.153041e-2	1	6.153041e-2	1.000000e+0	55	2.777008e-2	1.000000e+0	1.000000e+0	3.600998e+1	2.777008e-2	1	501	1.000000e+0	1.996008e-3	unnamed	PRPF31
Human Phenotype	HP:0004323	Abnormality of body weight	63	6.465988e-2	1.000000e+0	1.000000e+0	1.546554e+1	6.465988e-2	1	6.465988e-2	1.000000e+0	63	3.325758e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	600	1.000000e+0	1.666667e-3	unnamed	PRPF31
Human Phenotype	HP:0000812	Abnormal internal genitalia	64	6.482038e-2	1.000000e+0	1.000000e+0	1.542725e+1	6.482038e-2	1	6.482038e-2	1.000000e+0	56	3.081869e-2	1.000000e+0	1.000000e+0	3.244784e+1	3.081869e-2	1	556	1.000000e+0	1.798561e-3	unnamed	PRPF31
Human Phenotype	HP:0004328	Abnormality of the anterior segment of the eye	65	6.610995e-2	1.000000e+0	1.000000e+0	1.512632e+1	6.610995e-2	1	6.610995e-2	1.000000e+0	66	3.458788e-2	1.000000e+0	1.000000e+0	2.891186e+1	3.458788e-2	1	624	1.000000e+0	1.602564e-3	unnamed	PRPF31
Human Phenotype	HP:0003549	Abnormality of connective tissue	66	6.968666e-2	1.000000e+0	1.000000e+0	1.434995e+1	6.968666e-2	1	6.968666e-2	1.000000e+0	66	3.458788e-2	1.000000e+0	1.000000e+0	2.891186e+1	3.458788e-2	1	624	1.000000e+0	1.602564e-3	unnamed	PRPF31
Human Phenotype	HP:0012243	Abnormal genital system morphology	67	7.339808e-2	1.000000e+0	1.000000e+0	1.362434e+1	7.339808e-2	1	7.339808e-2	1.000000e+0	65	3.414445e-2	1.000000e+0	1.000000e+0	2.928734e+1	3.414445e-2	1	616	1.000000e+0	1.623377e-3	unnamed	PRPF31
Human Phenotype	HP:0000365	Hearing impairment	68	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	68	3.719306e-2	1.000000e+0	1.000000e+0	2.688674e+1	3.719306e-2	1	671	1.000000e+0	1.490313e-3	unnamed	PRPF31
Human Phenotype	HP:0000364	Hearing abnormality	69	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	69	3.796907e-2	1.000000e+0	1.000000e+0	2.633723e+1	3.796907e-2	1	685	1.000000e+0	1.459854e-3	unnamed	PRPF31
Human Phenotype	HP:0000078	Abnormality of the genital system	70	7.832480e-2	1.000000e+0	1.000000e+0	1.276735e+1	7.832480e-2	1	7.832480e-2	1.000000e+0	70	3.830165e-2	1.000000e+0	1.000000e+0	2.610854e+1	3.830165e-2	1	691	1.000000e+0	1.447178e-3	unnamed	PRPF31
Human Phenotype	HP:0011354	Generalized abnormality of skin	71	7.852036e-2	1.000000e+0	1.000000e+0	1.273555e+1	7.852036e-2	1	7.852036e-2	1.000000e+0	73	4.789092e-2	1.000000e+0	1.000000e+0	2.088079e+1	4.789092e-2	1	864	1.000000e+0	1.157407e-3	unnamed	PRPF31
Human Phenotype	HP:0011442	Abnormality of central motor function	72	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	72	4.484230e-2	1.000000e+0	1.000000e+0	2.230037e+1	4.484230e-2	1	809	1.000000e+0	1.236094e-3	unnamed	PRPF31
Human Phenotype	HP:0000366	Abnormality of the nose	73	8.197813e-2	1.000000e+0	1.000000e+0	1.219838e+1	8.197813e-2	1	8.197813e-2	1.000000e+0	71	3.996453e-2	1.000000e+0	1.000000e+0	2.502219e+1	3.996453e-2	1	721	1.000000e+0	1.386963e-3	unnamed	PRPF31
Human Phenotype	HP:0000951	Abnormality of the skin	74	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	75	5.664874e-2	1.000000e+0	1.000000e+0	1.765264e+1	5.664874e-2	1	1022	1.000000e+0	9.784736e-4	unnamed	PRPF31
Human Phenotype	HP:0000598	Abnormality of the ear	75	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	74	5.459786e-2	1.000000e+0	1.000000e+0	1.831574e+1	5.459786e-2	1	985	1.000000e+0	1.015228e-3	unnamed	PRPF31
Human Phenotype	HP:0012373	Abnormal eye physiology	76	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	77	5.858877e-2	1.000000e+0	1.000000e+0	1.706812e+1	5.858877e-2	1	1057	1.000000e+0	9.460738e-4	unnamed	PRPF31
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	77	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	76	5.831162e-2	1.000000e+0	1.000000e+0	1.714924e+1	5.831162e-2	1	1052	1.000000e+0	9.505703e-4	unnamed	PRPF31
Human Phenotype	HP:0012374	Abnormality of the globe	78	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	78	5.875506e-2	1.000000e+0	1.000000e+0	1.701981e+1	5.875506e-2	1	1060	1.000000e+0	9.433962e-4	unnamed	PRPF31
Human Phenotype	HP:0012372	Abnormal eye morphology	79	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	80	6.058422e-2	1.000000e+0	1.000000e+0	1.650595e+1	6.058422e-2	1	1093	1.000000e+0	9.149131e-4	unnamed	PRPF31
Human Phenotype	HP:0001507	Growth abnormality	80	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	79	5.980821e-2	1.000000e+0	1.000000e+0	1.672011e+1	5.980821e-2	1	1079	1.000000e+0	9.267841e-4	unnamed	PRPF31
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	81	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	82	6.241339e-2	1.000000e+0	1.000000e+0	1.602220e+1	6.241339e-2	1	1126	1.000000e+0	8.880995e-4	unnamed	PRPF31
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	82	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	87	7.344382e-2	1.000000e+0	1.000000e+0	1.361585e+1	7.344382e-2	1	1325	1.000000e+0	7.547170e-4	unnamed	PRPF31
Human Phenotype	HP:0000006	Autosomal dominant inheritance	83	1.208130e-1	1.000000e+0	1.000000e+0	8.277255e+0	1.208130e-1	1	1.208130e-1	1.000000e+0	81	6.147109e-2	1.000000e+0	1.000000e+0	1.626781e+1	6.147109e-2	1	1109	1.000000e+0	9.017133e-4	unnamed	PRPF31
Human Phenotype	HP:0001574	Abnormality of the integument	84	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	83	6.784546e-2	1.000000e+0	1.000000e+0	1.473938e+1	6.784546e-2	1	1224	1.000000e+0	8.169935e-4	unnamed	PRPF31
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	85	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	84	6.839976e-2	1.000000e+0	1.000000e+0	1.461994e+1	6.839976e-2	1	1234	1.000000e+0	8.103728e-4	unnamed	PRPF31
Human Phenotype	HP:0100543	Cognitive impairment	86	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	85	6.878776e-2	1.000000e+0	1.000000e+0	1.453747e+1	6.878776e-2	1	1241	1.000000e+0	8.058018e-4	unnamed	PRPF31
Human Phenotype	HP:0000271	Abnormality of the face	87	1.330333e-1	1.000000e+0	1.000000e+0	7.516916e+0	1.330333e-1	1	1.330333e-1	1.000000e+0	86	7.039521e-2	1.000000e+0	1.000000e+0	1.420551e+1	7.039521e-2	1	1270	1.000000e+0	7.874016e-4	unnamed	PRPF31
Human Phenotype	HP:0000478	Abnormality of the eye	88	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	88	7.715759e-2	1.000000e+0	1.000000e+0	1.296049e+1	7.715759e-2	1	1392	1.000000e+0	7.183908e-4	unnamed	PRPF31
Human Phenotype	HP:0011446	Abnormality of higher mental function	89	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	89	7.843246e-2	1.000000e+0	1.000000e+0	1.274982e+1	7.843246e-2	1	1415	1.000000e+0	7.067138e-4	unnamed	PRPF31
Human Phenotype	HP:0000234	Abnormality of the head	90	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	90	7.893132e-2	1.000000e+0	1.000000e+0	1.266924e+1	7.893132e-2	1	1424	1.000000e+0	7.022472e-4	unnamed	PRPF31
Human Phenotype	HP:0000152	Abnormality of head and neck	91	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	91	8.031706e-2	1.000000e+0	1.000000e+0	1.245066e+1	8.031706e-2	1	1449	1.000000e+0	6.901311e-4	unnamed	PRPF31
Human Phenotype	HP:0002011	Abnormality of the central nervous system	92	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	92	9.567097e-2	1.000000e+0	1.000000e+0	1.045249e+1	9.567097e-2	1	1726	1.000000e+0	5.793743e-4	unnamed	PRPF31
Human Phenotype	HP:0000707	Abnormality of the nervous system	93	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	93	1.001607e-1	1.000000e+0	1.000000e+0	9.983951e+0	1.001607e-1	1	1807	1.000000e+0	5.534034e-4	unnamed	PRPF31
Human Phenotype	HP:0000005	Mode of inheritance	94	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	94	1.452248e-1	1.000000e+0	1.000000e+0	6.885878e+0	1.452248e-1	1	2620	1.000000e+0	3.816794e-4	unnamed	PRPF31
Human Phenotype	HP:0000118	Phenotypic abnormality	95	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	95	1.548140e-1	1.000000e+0	1.000000e+0	6.459363e+0	1.548140e-1	1	2793	1.000000e+0	3.580380e-4	unnamed	PRPF31
Human Phenotype	HP:0000001	All	96	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	96	1.564215e-1	1.000000e+0	1.000000e+0	6.392984e+0	1.564215e-1	1	2822	1.000000e+0	3.543586e-4	unnamed	PRPF31
Disease Ontology	DOID:10584	retinitis pigmentosa	1	6.647729e-3	1.000000e+0	1.000000e+0	1.504273e+2	6.647729e-3	1	6.647729e-3	1.000000e+0	1	3.990910e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	72	1.000000e+0	1.388889e-2	unnamed	PRPF31
Disease Ontology	DOID:3612	retinitis	2	7.455033e-3	1.000000e+0	1.000000e+0	1.341376e+2	7.455033e-3	1	7.455033e-3	1.000000e+0	2	4.545203e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	82	1.000000e+0	1.219512e-2	unnamed	PRPF31
Disease Ontology	DOID:8466	retinal degeneration	3	2.566578e-2	1.000000e+0	1.000000e+0	3.896239e+1	2.566578e-2	1	2.566578e-2	1.000000e+0	3	1.363561e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	246	1.000000e+0	4.065041e-3	unnamed	PRPF31
Disease Ontology	DOID:5679	retinal disease	4	4.769824e-2	1.000000e+0	1.000000e+0	2.096514e+1	4.769824e-2	1	4.769824e-2	1.000000e+0	4	2.455518e-2	1.000000e+0	1.000000e+0	4.072460e+1	2.455518e-2	1	443	1.000000e+0	2.257336e-3	unnamed	PRPF31
Disease Ontology	DOID:5614	eye disease	5	6.845790e-2	1.000000e+0	1.000000e+0	1.460752e+1	6.845790e-2	1	6.845790e-2	1.000000e+0	5	3.503132e-2	1.000000e+0	1.000000e+0	2.854589e+1	3.503132e-2	1	632	1.000000e+0	1.582278e-3	unnamed	PRPF31
Disease Ontology	DOID:0050155	sensory system disease	6	7.608032e-2	1.000000e+0	1.000000e+0	1.314400e+1	7.608032e-2	1	7.608032e-2	1.000000e+0	6	3.913309e-2	1.000000e+0	1.000000e+0	2.555382e+1	3.913309e-2	1	706	1.000000e+0	1.416431e-3	unnamed	PRPF31
Disease Ontology	DOID:863	nervous system disease	7	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	7	1.428413e-1	1.000000e+0	1.000000e+0	7.000776e+0	1.428413e-1	1	2577	1.000000e+0	3.880481e-4	unnamed	PRPF31
Disease Ontology	DOID:7	disease of anatomical entity	8	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	8	3.268666e-1	1.000000e+0	1.000000e+0	3.059352e+0	3.268666e-1	1	5897	1.000000e+0	1.695778e-4	unnamed	PRPF31
Disease Ontology	DOID:4	disease	9	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	9	4.371155e-1	1.000000e+0	1.000000e+0	2.287725e+0	4.371155e-1	1	7886	1.000000e+0	1.268070e-4	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_CUL1	Neighborhood of CUL1	1	3.539075e-3	1.000000e+0	1.000000e+0	2.825597e+2	3.539075e-3	1	3.539075e-3	1.000000e+0	2	3.824622e-3	1.000000e+0	8.165568e-1	2.614638e+2	3.824622e-3	1	69	1.000000e+0	1.449275e-2	unnamed	PRPF31
MSigDB Cancer Neighborhood	GNF2_ELAC2	Neighborhood of ELAC2	2	3.679629e-3	1.000000e+0	7.856008e-1	2.717665e+2	3.679629e-3	1	3.679629e-3	1.000000e+0	1	2.549748e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	46	1.000000e+0	2.173913e-2	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_MAP2K2	Neighborhood of MAP2K2	3	5.257913e-3	1.000000e+0	7.483763e-1	1.901895e+2	5.257913e-3	1	5.257913e-3	1.000000e+0	5	7.261238e-3	1.000000e+0	6.201097e-1	1.377176e+2	7.261238e-3	1	131	1.000000e+0	7.633588e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	GNF2_KPNB1	Neighborhood of KPNB1	4	7.202355e-3	1.000000e+0	7.688514e-1	1.388435e+2	7.202355e-3	1	7.202355e-3	1.000000e+0	3	4.046339e-3	1.000000e+0	5.759289e-1	2.471370e+2	4.046339e-3	1	73	1.000000e+0	1.369863e-2	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_PPP2CA	Neighborhood of PPP2CA	5	8.679521e-3	1.000000e+0	7.412311e-1	1.152137e+2	8.679521e-3	1	8.679521e-3	1.000000e+0	4	7.150380e-3	1.000000e+0	7.633031e-1	1.398527e+2	7.150380e-3	1	129	1.000000e+0	7.751938e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_AATF	Neighborhood of AATF	6	1.135491e-2	1.000000e+0	8.080911e-1	8.806762e+1	1.135491e-2	1	1.135491e-2	1.000000e+0	9	1.141844e-2	1.000000e+0	5.417415e-1	8.757767e+1	1.141844e-2	1	206	1.000000e+0	4.854369e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_RPA2	Neighborhood of RPA2	7	1.157568e-2	1.000000e+0	7.061165e-1	8.638799e+1	1.157568e-2	1	1.157568e-2	1.000000e+0	7	1.058700e-2	1.000000e+0	6.458070e-1	9.445550e+1	1.058700e-2	1	191	1.000000e+0	5.235602e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_HAT1	Neighborhood of HAT1	8	1.209821e-2	1.000000e+0	6.457420e-1	8.265689e+1	1.209821e-2	1	1.209821e-2	1.000000e+0	6	9.700127e-3	1.000000e+0	6.903257e-1	1.030914e+2	9.700127e-3	1	175	1.000000e+0	5.714286e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_PRKDC	Neighborhood of PRKDC	9	1.236538e-2	1.000000e+0	5.866686e-1	8.087092e+1	1.236538e-2	1	1.236538e-2	1.000000e+0	7	1.058700e-2	1.000000e+0	6.458070e-1	9.445550e+1	1.058700e-2	1	191	1.000000e+0	5.235602e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_DDB1	Neighborhood of DDB1	10	1.302467e-2	1.000000e+0	5.561534e-1	7.677736e+1	1.302467e-2	1	1.302467e-2	1.000000e+0	11	1.330303e-2	1.000000e+0	5.163994e-1	7.517083e+1	1.330303e-2	1	240	1.000000e+0	4.166667e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_EIF3S2	Neighborhood of EIF3S2	11	1.367609e-2	1.000000e+0	5.308809e-1	7.312033e+1	1.367609e-2	1	1.367609e-2	1.000000e+0	12	1.363561e-2	1.000000e+0	4.852005e-1	7.333740e+1	1.363561e-2	1	246	1.000000e+0	4.065041e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_CSNK2B	Neighborhood of CSNK2B	12	1.463860e-2	1.000000e+0	5.208902e-1	6.831256e+1	1.463860e-2	1	1.463860e-2	1.000000e+0	17	1.596364e-2	1.000000e+0	4.009691e-1	6.264236e+1	1.596364e-2	1	288	1.000000e+0	3.472222e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_XRCC5	Neighborhood of XRCC5	13	1.540870e-2	1.000000e+0	5.061165e-1	6.489838e+1	1.540870e-2	1	1.540870e-2	1.000000e+0	10	1.319217e-2	1.000000e+0	5.633057e-1	7.580252e+1	1.319217e-2	1	238	1.000000e+0	4.201681e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_BUB3	Neighborhood of BUB3	14	1.577193e-2	1.000000e+0	4.810439e-1	6.340380e+1	1.577193e-2	1	1.577193e-2	1.000000e+0	14	1.540935e-2	1.000000e+0	4.699852e-1	6.489568e+1	1.540935e-2	1	278	1.000000e+0	3.597122e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_SOD1	Neighborhood of SOD1	15	1.778344e-2	1.000000e+0	5.062353e-1	5.623208e+1	1.778344e-2	1	1.778344e-2	1.000000e+0	16	1.552020e-2	1.000000e+0	4.141953e-1	6.443214e+1	1.552020e-2	1	280	1.000000e+0	3.571429e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_DEK	Neighborhood of DEK	16	1.800421e-2	1.000000e+0	4.804874e-1	5.554256e+1	1.800421e-2	1	1.800421e-2	1.000000e+0	13	1.452248e-2	1.000000e+0	4.770076e-1	6.885878e+1	1.452248e-2	1	262	1.000000e+0	3.816794e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_HDAC2	Neighborhood of HDAC2	17	2.010072e-2	1.000000e+0	5.048828e-1	4.974947e+1	2.010072e-2	1	2.010072e-2	1.000000e+0	14	1.540935e-2	1.000000e+0	4.699852e-1	6.489568e+1	1.540935e-2	1	278	1.000000e+0	3.597122e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_GNB1	Neighborhood of GNB1	18	2.039438e-2	1.000000e+0	4.838000e-1	4.903311e+1	2.039438e-2	1	2.039438e-2	1.000000e+0	18	1.696137e-2	1.000000e+0	4.023614e-1	5.895752e+1	1.696137e-2	1	306	1.000000e+0	3.267974e-3	unnamed	PRPF31
MSigDB Cancer Neighborhood	MORF_RAD23A	Neighborhood of RAD23A	19	2.178384e-2	1.000000e+0	4.895631e-1	4.590559e+1	2.178384e-2	1	2.178384e-2	1.000000e+0	19	1.940025e-2	1.000000e+0	4.359951e-1	5.154571e+1	1.940025e-2	1	350	1.000000e+0	2.857143e-3	unnamed	PRPF31
MSigDB Pathway	KEGG_SPLICEOSOME	Spliceosome	1	6.382505e-3	1.000000e+0	1.000000e+0	1.566783e+2	6.382505e-3	1	6.382505e-3	1.000000e+0	1	6.928662e-3	1.000000e+0	1.000000e+0	1.443280e+2	6.928662e-3	1	125	1.000000e+0	8.000000e-3	unnamed	PRPF31
MGI Expression: Detected	6925	TS23_embryo	1	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	1	4.840086e-1	1.000000e+0	1.000000e+0	2.066079e+0	4.840086e-1	1	8732	1.000000e+0	1.145213e-4	unnamed	PRPF31
MGI Expression: Detected	6924	Theiler_stage_23	2	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	2	4.841749e-1	1.000000e+0	1.000000e+0	2.065369e+0	4.841749e-1	1	8735	1.000000e+0	1.144820e-4	unnamed	PRPF31
MSigDB Perturbation	NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON	Genes within amplicon 19q13.4 identified in a copy number alterations study of 191 breast tumor samples.	1	7.706959e-5	2.592621e-1	2.592621e-1	1.297529e+4	7.706959e-5	1	7.706959e-5	1.000000e+0	2	3.880051e-4	1.000000e+0	6.526246e-1	2.577286e+3	3.880051e-4	1	7	1.000000e+0	1.428571e-1	unnamed	PRPF31
MSigDB Perturbation	CHEN_HOXA5_TARGETS_6HR_DN	Genes down-regulated 6 h after induction of HoxA5 [GeneID=3205] expression in a breast cancer cell line.	2	1.309980e-4	4.406773e-1	2.203386e-1	7.633705e+3	1.309980e-4	1	1.309980e-4	1.000000e+0	1	2.771465e-4	9.323208e-1	9.323208e-1	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	PRPF31
MSigDB Perturbation	MEISSNER_NPC_ICP_WITH_H3K4ME3	Genes with intermediate-CpG-density promoters (ICP) bearing histone H3 trimethylation mark at K4 (H3K4me3) in neural precursor cells (NPC).	3	1.245379e-3	1.000000e+0	1.000000e+0	8.029685e+2	1.245379e-3	1	1.245379e-3	1.000000e+0	3	9.977274e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	18	1.000000e+0	5.555556e-2	unnamed	PRPF31
MSigDB Perturbation	MEISSNER_ES_ICP_WITH_H3K4ME3	Genes with intermediate-CpG-density promoters (ICP) bearing histone H3 trimethylation mark at K4 (H3K4me3) in ES cells (embryonic stem).	4	2.473994e-3	1.000000e+0	1.000000e+0	4.042047e+2	2.473994e-3	1	2.473994e-3	1.000000e+0	5	1.662879e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	30	1.000000e+0	3.333333e-2	unnamed	PRPF31
MSigDB Perturbation	MEISSNER_BRAIN_ICP_WITH_H3K4ME3	Genes with intermediate-CpG-density promoters (ICP) bearing histone H3 trimethylation mark at K4 (H3K4me3) in brain.	5	2.492642e-3	1.000000e+0	1.000000e+0	4.011808e+2	2.492642e-3	1	2.492642e-3	1.000000e+0	4	1.607450e-3	1.000000e+0	1.000000e+0	6.221034e+2	1.607450e-3	1	29	1.000000e+0	3.448276e-2	unnamed	PRPF31
MSigDB Perturbation	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	Down-regulated genes whose expression correlates with copy number losses in pancreatic adenocarcinoma cell lines and primary tumor specimens.	6	1.824244e-2	1.000000e+0	1.000000e+0	5.481722e+1	1.824244e-2	1	1.824244e-2	1.000000e+0	7	1.263788e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	228	1.000000e+0	4.385965e-3	unnamed	PRPF31
MSigDB Perturbation	DAIRKEE_TERT_TARGETS_UP	Genes up-regulated in non-spontaneously immortalizing (NSI) primary breast cancer tumor cultures upon expression of TERT [GeneID=7015] off a retroviral vector.	7	2.095337e-2	1.000000e+0	1.000000e+0	4.772503e+1	2.095337e-2	1	2.095337e-2	1.000000e+0	10	2.012084e-2	1.000000e+0	1.000000e+0	4.969972e+1	2.012084e-2	1	363	1.000000e+0	2.754821e-3	unnamed	PRPF31
MSigDB Perturbation	VERHAAK_GLIOBLASTOMA_CLASSICAL	Genes correlated with classical type of glioblastoma multiforme tumors.	8	3.391831e-2	1.000000e+0	1.000000e+0	2.948260e+1	3.391831e-2	1	3.391831e-2	1.000000e+0	6	1.125215e-2	1.000000e+0	1.000000e+0	8.887192e+1	1.125215e-2	1	203	1.000000e+0	4.926108e-3	unnamed	PRPF31
MSigDB Perturbation	BENPORATH_OCT4_TARGETS	Set 'Oct4 targets': genes upregulated and identified by ChIP on chip as OCT4 [GeneID=5460] transcription factor targets in human embryonic stem cells.	9	4.396975e-2	1.000000e+0	1.000000e+0	2.274291e+1	4.396975e-2	1	4.396975e-2	1.000000e+0	8	1.568649e-2	1.000000e+0	1.000000e+0	6.374912e+1	1.568649e-2	1	283	1.000000e+0	3.533569e-3	unnamed	PRPF31
MSigDB Perturbation	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	Genes down-regulated in HEK-293 cells (fibroblast) upon knockdown of CTBP1 but not of SATB1 [GeneID=1487, 6304] by RNAi.	10	4.677513e-2	1.000000e+0	1.000000e+0	2.137888e+1	4.677513e-2	1	4.677513e-2	1.000000e+0	12	2.366831e-2	1.000000e+0	1.000000e+0	4.225059e+1	2.366831e-2	1	427	1.000000e+0	2.341920e-3	unnamed	PRPF31
MSigDB Perturbation	KIM_WT1_TARGETS_DN	Genes down-regulated in UB27 cells (osteosarcoma) at any time point after inducing the expression of a mutant form of WT1 [GeneID=7490].	11	4.691887e-2	1.000000e+0	1.000000e+0	2.131339e+1	4.691887e-2	1	4.691887e-2	1.000000e+0	13	2.477690e-2	1.000000e+0	1.000000e+0	4.036018e+1	2.477690e-2	1	447	1.000000e+0	2.237136e-3	unnamed	PRPF31
MSigDB Perturbation	JOHNSTONE_PARVB_TARGETS_2_DN	Genes down-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D collagen I and 3D Matrigel only.	12	4.806995e-2	1.000000e+0	1.000000e+0	2.080302e+1	4.806995e-2	1	4.806995e-2	1.000000e+0	9	1.784823e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	322	1.000000e+0	3.105590e-3	unnamed	PRPF31
MSigDB Perturbation	LIAO_METASTASIS	Genes up-regulated in the samples with intrahepatic metastatic hepatocellular carcinoma (HCC) vs primary HCC.	13	4.955050e-2	1.000000e+0	1.000000e+0	2.018143e+1	4.955050e-2	1	4.955050e-2	1.000000e+0	14	2.749293e-2	1.000000e+0	1.000000e+0	3.637298e+1	2.749293e-2	1	496	1.000000e+0	2.016129e-3	unnamed	PRPF31
MSigDB Perturbation	MIKKELSEN_NPC_ICP_WITH_H3K4ME3	Genes with low-CpG-density promoters (LCP) bearing histone H3 trimethylation mark at K4 (H3K4me3) in neural progenitor cells (NPC).	14	5.066138e-2	1.000000e+0	1.000000e+0	1.973890e+1	5.066138e-2	1	5.066138e-2	1.000000e+0	11	2.333574e-2	1.000000e+0	1.000000e+0	4.285273e+1	2.333574e-2	1	421	1.000000e+0	2.375297e-3	unnamed	PRPF31
MSigDB Perturbation	MIKKELSEN_ES_ICP_WITH_H3K4ME3	Genes with intermediate-CpG-density (ICP) promoters bearing histone H3 K4 trimethylation mark (H3K4me3) in embryonic stem cells (ES).	15	5.226929e-2	1.000000e+0	1.000000e+0	1.913169e+1	5.226929e-2	1	5.226929e-2	1.000000e+0	15	3.730392e-2	1.000000e+0	1.000000e+0	2.680684e+1	3.730392e-2	1	673	1.000000e+0	1.485884e-3	unnamed	PRPF31
MSigDB Perturbation	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	Genes down-regulated in ME-A cells (breast cancer, sensitive to apoptotic stimuli) exposed to doxorubicin [PubChem=31703] in the presence of medium concentrate (MC) from ME-C cells (breast cancer, resistant to apoptotic stimuli).	16	6.489857e-2	1.000000e+0	1.000000e+0	1.540866e+1	6.489857e-2	1	6.489857e-2	1.000000e+0	16	4.135026e-2	1.000000e+0	1.000000e+0	2.418365e+1	4.135026e-2	1	746	1.000000e+0	1.340483e-3	unnamed	PRPF31
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 6 h.	17	6.654607e-2	1.000000e+0	1.000000e+0	1.502718e+1	6.654607e-2	1	6.654607e-2	1.000000e+0	17	4.755834e-2	1.000000e+0	1.000000e+0	2.102681e+1	4.755834e-2	1	858	1.000000e+0	1.165501e-3	unnamed	PRPF31
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 24 h.	18	7.774937e-2	1.000000e+0	1.000000e+0	1.286184e+1	7.774937e-2	1	7.774937e-2	1.000000e+0	19	5.276869e-2	1.000000e+0	1.000000e+0	1.895063e+1	5.276869e-2	1	952	1.000000e+0	1.050420e-3	unnamed	PRPF31
MSigDB Perturbation	JOHNSTONE_PARVB_TARGETS_3_DN	Genes down-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D Matrigel only.	19	8.753961e-2	1.000000e+0	1.000000e+0	1.142340e+1	8.753961e-2	1	8.753961e-2	1.000000e+0	18	4.772463e-2	1.000000e+0	1.000000e+0	2.095354e+1	4.772463e-2	1	861	1.000000e+0	1.161440e-3	unnamed	PRPF31
MSigDB Perturbation	BENPORATH_NANOG_TARGETS	Set 'Nanog targets': genes upregulated and identified by ChIP on chip as Nanog [GeneID=79923] transcription factor targets in human embryonic stem cells.	20	1.005508e-1	1.000000e+0	1.000000e+0	9.945225e+0	1.005508e-1	1	1.005508e-1	1.000000e+0	20	5.398814e-2	1.000000e+0	1.000000e+0	1.852259e+1	5.398814e-2	1	974	1.000000e+0	1.026694e-3	unnamed	PRPF31
MSigDB Perturbation	PUJANA_ATM_PCC_NETWORK	Genes constituting the ATM-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of ATM [GeneID=472] across a compendium of normal tissues.	21	1.248339e-1	1.000000e+0	1.000000e+0	8.010648e+0	1.248339e-1	1	1.248339e-1	1.000000e+0	21	7.848789e-2	1.000000e+0	1.000000e+0	1.274082e+1	7.848789e-2	1	1416	1.000000e+0	7.062147e-4	unnamed	PRPF31
MSigDB Perturbation	PUJANA_BRCA1_PCC_NETWORK	Genes constituting the BRCA1-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA1 [GeneID=672] across a compendium of normal tissues.	22	1.292550e-1	1.000000e+0	1.000000e+0	7.736644e+0	1.292550e-1	1	1.292550e-1	1.000000e+0	22	9.068233e-2	1.000000e+0	1.000000e+0	1.102751e+1	9.068233e-2	1	1636	1.000000e+0	6.112469e-4	unnamed	PRPF31
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN	Genes down-regulated in ME-A cells (breast cancer) undergoing apoptosis in response to doxorubicin [PubChem=31703].	23	1.826173e-1	1.000000e+0	1.000000e+0	5.475932e+0	1.826173e-1	1	1.826173e-1	1.000000e+0	23	9.600355e-2	1.000000e+0	1.000000e+0	1.041628e+1	9.600355e-2	1	1732	1.000000e+0	5.773672e-4	unnamed	PRPF31
MSigDB Predicted Promoter Motifs	V$CREB_Q3	Motif CGTCAN matches CREB1: cAMP responsive element binding protein 1	1	2.828458e-2	1.000000e+0	1.000000e+0	3.535495e+1	2.828458e-2	1	2.828458e-2	1.000000e+0	1	1.330303e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	240	1.000000e+0	4.166667e-3	unnamed	PRPF31
MSigDB Predicted Promoter Motifs	RRAGTTGT_UNKNOWN	Motif RRAGTTGT (no known TF)	2	4.322274e-2	1.000000e+0	1.000000e+0	2.313597e+1	4.322274e-2	1	4.322274e-2	1.000000e+0	2	1.346932e-2	1.000000e+0	1.000000e+0	7.424280e+1	1.346932e-2	1	243	1.000000e+0	4.115226e-3	unnamed	PRPF31
MSigDB Predicted Promoter Motifs	GATTGGY_V$NFY_Q6_01	Motif GATTGGY (no known TF)	3	1.117321e-1	1.000000e+0	1.000000e+0	8.949976e+0	1.117321e-1	1	1.117321e-1	1.000000e+0	3	6.280140e-2	1.000000e+0	1.000000e+0	1.592321e+1	6.280140e-2	1	1133	1.000000e+0	8.826125e-4	unnamed	PRPF31
MSigDB Predicted Promoter Motifs	AACTTT_UNKNOWN	Motif AACTTT (no known TF)	4	2.964325e-1	1.000000e+0	1.000000e+0	3.373449e+0	2.964325e-1	1	2.964325e-1	1.000000e+0	4	1.009922e-1	1.000000e+0	1.000000e+0	9.901756e+0	1.009922e-1	1	1822	1.000000e+0	5.488474e-4	unnamed	PRPF31
InterPro	IPR019175	Prp31 C-terminal	1	3.749979e-6	3.533230e-2	3.533230e-2	2.666681e+5	3.749979e-6	1	3.749979e-6	1.000000e+0	1	5.542930e-5	5.222549e-1	5.222549e-1	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	PRPF31
InterPro	IPR027105	U4/U6 small nuclear ribonucleoprotein Prp31	1	3.749979e-6	3.533230e-2	3.533230e-2	2.666681e+5	3.749979e-6	1	3.749979e-6	1.000000e+0	1	5.542930e-5	5.222549e-1	5.222549e-1	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	PRPF31
InterPro	IPR002687	Nop domain	3	9.249832e-5	8.715192e-1	2.905064e-1	1.081101e+4	9.249832e-5	1	9.249832e-5	1.000000e+0	3	1.662879e-4	1.000000e+0	5.222549e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	PRPF31
InterPro	IPR012976	NOSIC	3	9.249832e-5	8.715192e-1	2.905064e-1	1.081101e+4	9.249832e-5	1	9.249832e-5	1.000000e+0	3	1.662879e-4	1.000000e+0	5.222549e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	PRPF31
TreeFam	TF300677	PRPF31	1	3.749979e-6	3.047233e-2	3.047233e-2	2.666681e+5	3.749979e-6	1	3.749979e-6	1.000000e+0	1	5.542930e-5	4.504185e-1	4.504185e-1	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	PRPF31
Ensembl Genes	10485	PRPF31	1	3.749979e-6	6.765337e-2	6.765337e-2	2.666681e+5	3.749979e-6	1	3.749979e-6	1.000000e+0	1	5.542930e-5	1.000000e+0	1.000000e+0	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP	Genes up-regulated in peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of diagnosis versus those with type 2 diabetes at the time of diagnosis.	1	5.844112e-3	1.000000e+0	1.000000e+0	1.711124e+2	5.844112e-3	1	5.844112e-3	1.000000e+0	14	1.086414e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	196	1.000000e+0	5.102041e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 2 diabetes at the time of diagnosis.	2	8.628608e-3	1.000000e+0	1.000000e+0	1.158936e+2	8.628608e-3	1	8.628608e-3	1.000000e+0	19	1.097500e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	198	1.000000e+0	5.050505e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 48 h.	3	1.168167e-2	1.000000e+0	1.000000e+0	8.560422e+1	1.168167e-2	1	1.168167e-2	1.000000e+0	19	1.097500e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	198	1.000000e+0	5.050505e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute influenza infection.	4	1.190622e-2	1.000000e+0	1.000000e+0	8.398968e+1	1.190622e-2	1	1.190622e-2	1.000000e+0	1	9.034976e-3	1.000000e+0	1.000000e+0	1.106810e+2	9.034976e-3	1	163	1.000000e+0	6.134969e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 48 h after stimulation with antigen-B7-1.	5	1.307265e-2	1.000000e+0	1.000000e+0	7.649557e+1	1.307265e-2	1	1.307265e-2	1.000000e+0	16	1.091957e-2	1.000000e+0	1.000000e+0	9.157868e+1	1.091957e-2	1	197	1.000000e+0	5.076142e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN	Genes down-regulated in comparison of memory CD8 T cells treated with IL7 [GeneID=3574] versus naive CD8 T cells treated with IL7 [GeneID=3574].	6	1.346264e-2	1.000000e+0	1.000000e+0	7.427964e+1	1.346264e-2	1	1.346264e-2	1.000000e+0	6	1.053157e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	190	1.000000e+0	5.263158e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 8 h.	7	1.374471e-2	1.000000e+0	1.000000e+0	7.275528e+1	1.374471e-2	1	1.374471e-2	1.000000e+0	4	1.036528e-2	1.000000e+0	1.000000e+0	9.647594e+1	1.036528e-2	1	187	1.000000e+0	5.347594e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE22886_IL2_VS_IL15_STIM_NKCELL_DN	Genes down-regulated in comparison of NK cells stimulated with IL2 [GeneID=3558] at 16 h versus NK cells stimulated with IL15 [GeneID=3600] at 16 h.	8	1.389040e-2	1.000000e+0	1.000000e+0	7.199218e+1	1.389040e-2	1	1.389040e-2	1.000000e+0	3	1.019899e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	184	1.000000e+0	5.434783e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE339_CD4POS_VS_CD4CD8DN_DC_UP	Genes up-regulated in comparison of CD4 [GeneID=920] dendritic cells (DC) versus CD4- [GeneID=920] CD8- DCs.	9	1.424311e-2	1.000000e+0	1.000000e+0	7.020941e+1	1.424311e-2	1	1.424311e-2	1.000000e+0	16	1.091957e-2	1.000000e+0	1.000000e+0	9.157868e+1	1.091957e-2	1	197	1.000000e+0	5.076142e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN	Genes down-regulated in comparison of unstimulated memory CD4 [GeneID=920] CD8 T cells versus stimulated CD4 [GeneID=920] CD8 T cells.	10	1.447164e-2	1.000000e+0	1.000000e+0	6.910068e+1	1.447164e-2	1	1.447164e-2	1.000000e+0	16	1.091957e-2	1.000000e+0	1.000000e+0	9.157868e+1	1.091957e-2	1	197	1.000000e+0	5.076142e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN	Genes down-regulated in comparison of memory CD8 T cells treated with IL7 [GeneID=3574] versus those treated with IL4 [GeneID=3565].	11	1.459397e-2	1.000000e+0	1.000000e+0	6.852145e+1	1.459397e-2	1	1.459397e-2	1.000000e+0	9	1.069785e-2	1.000000e+0	1.000000e+0	9.347668e+1	1.069785e-2	1	193	1.000000e+0	5.181347e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC stimulated with YF17D vaccine.	12	1.462937e-2	1.000000e+0	1.000000e+0	6.835564e+1	1.462937e-2	1	1.462937e-2	1.000000e+0	8	1.064243e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	192	1.000000e+0	5.208333e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN	Genes down-regulated in comparison of microglia cells 6 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.	13	1.500117e-2	1.000000e+0	1.000000e+0	6.666145e+1	1.500117e-2	1	1.500117e-2	1.000000e+0	12	1.080871e-2	1.000000e+0	1.000000e+0	9.251795e+1	1.080871e-2	1	195	1.000000e+0	5.128205e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN	Genes down-regulated in comparison of lung tissue from wild type mice subjected to ozone for 48 h versus that from TLR4 [GeneID=7099] deficient mice subjected to ozone for 48 h.	14	1.507682e-2	1.000000e+0	1.000000e+0	6.632700e+1	1.507682e-2	1	1.507682e-2	1.000000e+0	10	1.075328e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	194	1.000000e+0	5.154639e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN	Genes down-regulated in comparison of lung tissue from wild type mice subjected to ozone for 0 h versus that from TLR4 [GeneID=7099] deficient mice subjected to ozone for 48 h.	15	1.621704e-2	1.000000e+0	1.000000e+0	6.166354e+1	1.621704e-2	1	1.621704e-2	1.000000e+0	22	1.114129e-2	1.000000e+0	9.672665e-1	8.975622e+1	1.114129e-2	1	201	1.000000e+0	4.975124e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 16 h.	16	1.718212e-2	1.000000e+0	1.000000e+0	5.820004e+1	1.718212e-2	1	1.718212e-2	1.000000e+0	7	1.058700e-2	1.000000e+0	1.000000e+0	9.445550e+1	1.058700e-2	1	191	1.000000e+0	5.235602e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN	Genes down-regulated in comparison of granulocytic myeloid derived suppressor cells (MDSC) versus neutrophils.	17	1.746443e-2	1.000000e+0	1.000000e+0	5.725924e+1	1.746443e-2	1	1.746443e-2	1.000000e+0	12	1.080871e-2	1.000000e+0	1.000000e+0	9.251795e+1	1.080871e-2	1	195	1.000000e+0	5.128205e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).	18	1.753859e-2	1.000000e+0	1.000000e+0	5.701713e+1	1.753859e-2	1	1.753859e-2	1.000000e+0	2	9.921845e-3	1.000000e+0	1.000000e+0	1.007877e+2	9.921845e-3	1	179	1.000000e+0	5.586592e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE13493_DP_VS_CD8POS_THYMOCYTE_DN	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus CD8 thymocytes.	19	1.788744e-2	1.000000e+0	1.000000e+0	5.590516e+1	1.788744e-2	1	1.788744e-2	1.000000e+0	10	1.075328e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	194	1.000000e+0	5.154639e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE2826_WT_VS_BTK_KO_BCELL_UP	Genes up-regulated in comparison of primary splenic B cells from wild type mice versus those from BTK [GeneID=695] knockout mice.	20	1.832401e-2	1.000000e+0	1.000000e+0	5.457322e+1	1.832401e-2	1	1.832401e-2	1.000000e+0	14	1.086414e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	196	1.000000e+0	5.102041e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE13306_TREG_RA_VS_TCONV_RA_UP	Genes up-regulated in regulatory T cell (Treg) treated with retinoic acid (tretinoin) [PubChem=444795] versus conventional T cells.	21	1.966243e-2	1.000000e+0	1.000000e+0	5.085840e+1	1.966243e-2	1	1.966243e-2	1.000000e+0	4	1.036528e-2	1.000000e+0	1.000000e+0	9.647594e+1	1.036528e-2	1	187	1.000000e+0	5.347594e-3	unnamed	PRPF31
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 4 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 4 h.	22	1.980860e-2	1.000000e+0	1.000000e+0	5.048313e+1	1.980860e-2	1	1.980860e-2	1.000000e+0	21	1.103043e-2	1.000000e+0	1.000000e+0	9.065829e+1	1.103043e-2	1	199	1.000000e+0	5.025126e-3	unnamed	PRPF31
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
